<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35170402</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>04</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>06</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1933-6969</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>16</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Dec</Month>
            </PubDate>
          </JournalIssue>
          <Title>Channels (Austin, Tex.)</Title>
          <ISOAbbreviation>Channels (Austin)</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Clinical and molecular characteristics of myotonia congenita in China: Case series and a literature review.</ArticleTitle>
        <Pagination>
          <StartPage>35</StartPage>
          <EndPage>46</EndPage>
          <MedlinePgn>35-46</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1080/19336950.2022.2041292</ELocationID>
        <Abstract>
          <AbstractText>Myotonia congenita (MC) is a rare genetic disease caused by mutations in the skeletal muscle chloride channel gene (<i>CLCN1</i>), encoding the voltage-gated chloride channel ClC-1 in skeletal muscle. Our study reported the clinical and molecular characteristics of six patients with MC and systematically review the literature on Chinese people. We retrospectively analyzed demographics, clinical features, family history, creatine kinase (CK), electromyography (EMG), treatment, and genotype data of our patients and reviewed the clinical data and <i>CLCN1</i> mutations in literature. The median ages at examination and onset were 26.5 years (range 11-50 years) and 6.5 years (range 1.5-11 years), respectively, in our patients, and 21 years (range 3.5-65 years, n = 45) and 9 years (range 0.5-26 years, n = 50), respectively, in literature. Similar to previous reports, myotonia involved limb, lids, masticatory, and trunk muscles to varying degrees. Warm-up phenomenon (5/6), percussion myotonia (3/5), and grip myotonia (6/6) were common. Menstruation triggered myotonia in females, not observed in Chinese patients before. The proportion of abnormal CK levels (4/5) was higher than data from literature. Electromyography performed in six patients revealed myotonic changes (100%). Five novel <i>CLCN1</i> mutations, including a splicing mutation (c.853 + 4A&gt;G), a deletion mutation (c.2010_2014del), and three missense mutations (c.2527C&gt;T, c.1727C&gt;T, c.2017 G &gt; C), were identified. The c.892 G &gt; A (p.A298T) mutation was the most frequent mutation in the Chinese population. Our study expanded the clinical and genetic spectrum of patients with MC in the China. The MC phenotype in Chinese people is not different from that found in the West, while the genotype is different.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Li</LastName>
            <ForeName>Yifan</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Geriatric Neurological Department of the Second Medical Center &amp; National Clinical Research Center for Geriatric Diseases, Chinese Pla General Hospital, Beijing, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Li</LastName>
            <ForeName>Mao</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology of the First Medical Center, Chinese Pla General Hospital, Beijing, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wang</LastName>
            <ForeName>Zhenfu</ForeName>
            <Initials>Z</Initials>
            <AffiliationInfo>
              <Affiliation>Geriatric Neurological Department of the Second Medical Center &amp; National Clinical Research Center for Geriatric Diseases, Chinese Pla General Hospital, Beijing, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Yang</LastName>
            <ForeName>Fei</ForeName>
            <Initials>F</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology of the First Medical Center, Chinese Pla General Hospital, Beijing, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wang</LastName>
            <ForeName>Hongfen</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology of the First Medical Center, Chinese Pla General Hospital, Beijing, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bai</LastName>
            <ForeName>Xiujuan</ForeName>
            <Initials>X</Initials>
            <AffiliationInfo>
              <Affiliation>Geriatric Neurological Department of the Second Medical Center &amp; National Clinical Research Center for Geriatric Diseases, Chinese Pla General Hospital, Beijing, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sun</LastName>
            <ForeName>Bo</ForeName>
            <Initials>B</Initials>
            <AffiliationInfo>
              <Affiliation>Geriatric Neurological Department of the Second Medical Center &amp; National Clinical Research Center for Geriatric Diseases, Chinese Pla General Hospital, Beijing, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chen</LastName>
            <ForeName>Siyu</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Geriatric Neurological Department of the Second Medical Center &amp; National Clinical Research Center for Geriatric Diseases, Chinese Pla General Hospital, Beijing, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Huang</LastName>
            <ForeName>Xusheng</ForeName>
            <Initials>X</Initials>
            <Identifier Source="ORCID">0000-0002-2451-0254</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Neurology of the First Medical Center, Chinese Pla General Hospital, Beijing, China.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <DataBankList CompleteYN="Y">
          <DataBank>
            <DataBankName>Dryad</DataBankName>
            <AccessionNumberList>
              <AccessionNumber>10.5061/dryad.0cfxpnw42</AccessionNumber>
            </AccessionNumberList>
          </DataBank>
        </DataBankList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Channels (Austin)</MedlineTA>
        <NlmUniqueID>101321614</NlmUniqueID>
        <ISSNLinking>1933-6950</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D018118">Chloride Channels</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D018118" MajorTopicYN="N">Chloride Channels</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009222" MajorTopicYN="Y">Myotonia</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009224" MajorTopicYN="Y">Myotonia Congenita</DescriptorName>
          <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="Y">CLCN1</Keyword>
        <Keyword MajorTopicYN="Y">Myotonia congenita</Keyword>
        <Keyword MajorTopicYN="Y">genotype</Keyword>
        <Keyword MajorTopicYN="Y">novel mutations</Keyword>
        <Keyword MajorTopicYN="Y">phenotype</Keyword>
      </KeywordList>
      <CoiStatement>No potential conflict of interest was reported by the author(s).</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>16</Day>
          <Hour>8</Hour>
          <Minute>42</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>17</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>6</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35170402</ArticleId>
        <ArticleId IdType="pmc">PMC8855856</ArticleId>
        <ArticleId IdType="doi">10.1080/19336950.2022.2041292</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Altamura C, Lucchiari S, Sahbani D, et al. The analysis of myotonia congenita mutations discloses functional clusters of amino acids within the CBS2 domain and the C-terminal peptide of the ClC-1 channel. Hum Mutat. 2018;39(9):1273–1283.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29935101</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Trivedi JR, Bundy B, Statland J, et al. Non-dystrophic myotonia: prospective study of objective and patient reported outcomes. Brain. 2013;136(Pt 7):2189–2200.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3692030</ArticleId>
            <ArticleId IdType="pubmed">23771340</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Koch MC, Steinmeyer K, Lorenz C, et al. The skeletal muscle chloride channel in dominant and recessive human myotonia. Science. 1992;257(5071):797–800.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1379744</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yang X, Jia H, An R, et al. Sequence CLCN1 and SCN4A in patients with Nondystrophic myotonias in Chinese populations: genetic and pedigree analysis of 10 families and review of the literature. Channels (Austin). 2017;11(1):55–65.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5279883</ArticleId>
            <ArticleId IdType="pubmed">27415035</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lossin C, George AL Jr. Myotonia congenita. Adv Genet. 2008;63:25–55.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19185184</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cherian A, Baheti NN, Kuruvilla A.. 
Muscle channelopathies and electrophysiological approach. Ann Indian Acad Neurol. 2008;11(1):20–27.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2781140</ArticleId>
            <ArticleId IdType="pubmed">19966974</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Colding-Jorgensen E. Phenotypic variability in myotonia congenita. Muscle Nerve. 2005;32(1):19–34.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15786415</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Plassart-Schiess E, Gervais A, Eymard B, et al. Novel muscle chloride channel (CLCN1) mutations in myotonia congenita with various modes of inheritance including incomplete dominance and penetrance. Neurology. 1998;50(4):1176–1179.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9566422</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hu C, Shi Y, Zhao L, et al. Myotonia congenita: clinical characteristic and mutation spectrum of CLCN1 in Chinese patients. Front Pediatr. 2021;9:759505.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8591224</ArticleId>
            <ArticleId IdType="pubmed">34790634</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kuo HC, Hsiao KM, Chang LI, et al. Novel mutations at carboxyl terminus of CIC-1 channel in myotonia congenita. Acta Neurol Scand. 2006;113(5):342–346.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16629771</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gao F, Ma FC, Yuan ZF, et al. Novel chloride channel gene mutations in two unrelated Chinese families with myotonia congenita. Neurol India. 2010;58(5):743–746.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21045501</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ma FC, Gao F, and Yuan ZF. Clinical analysis and gene mutation screening of CLCN1 in two myotonia congenita families. J Clin Pediatr. 2011;29(11):1041–1043. Chinese.</Citation>
        </Reference>
        <Reference>
          <Citation>Kong LN, Wu QY, and Shen YS, et al. Study of CLCN1 gene mutations in a family with myotonia congenital. J Clin Neurol. 2012;25(6):407–409. Chinese.</Citation>
        </Reference>
        <Reference>
          <Citation>Li HF, Chen WJ, Ni W, et al. Paroxysmal kinesigenic dyskinesia and myotonia congenita in the same family: coexistence of a PRRT2 mutation and two CLCN1 mutations. Neurosci Bull. 2014;30(6):1010–1016.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5562558</ArticleId>
            <ArticleId IdType="pubmed">25205014</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu XL, Huang XJ, Shen JY, et al. Myotonia congenita: novel mutations in CLCN1 gene. Channels (Austin). 2015;9(5):292–298.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4826137</ArticleId>
            <ArticleId IdType="pubmed">26260254</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gu P, Sun ZQ, Wang WT, et al. A case of myotonia congenita. J Chin J Nerv Ment Dis. 2017;43(6):377–378. Chinese.</Citation>
        </Reference>
        <Reference>
          <Citation>Jing F, Li H, Yang D, et al. Analysis of CLCN1 gene mutations in a family affected with myotonia congenita. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2018;35(3):400–402. Chinese.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29896741</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang W, Meng HX, Wang XM, et al. Identification of two novel compound heterozygous CLCN1 mutations associated with autosomal recessive myotonia congenita. Neurol Res. 2019;41(12):1069–1074.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31566103</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yang HJ, Zhao HJ, Yang XL. Clinical, electrophysiological, and genetic studies of one family and one sporadic patient with congenital myotonia. J Int Neurol Neurosurg. 2019;46(4):364–367. Chinese.</Citation>
        </Reference>
        <Reference>
          <Citation>Zhao CY, Tang DF, and Huang H, et al. Myotonia congenita and periodic hypokalemia paralysis in a consanguineous marriage pedigree: coexistence of a novel CLCN1 mutation and an SCN4A mutation. PLoS One. 2020;15(5):e0233017.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7224471</ArticleId>
            <ArticleId IdType="pubmed">32407401</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cao XL, Qin QY, Huang W. Clinical and genetic analysis for a family with myotonia congenita of CLCN1 gene mutations. Chin J Pract Nerv Dis. 2020;23(23):2112–2116. Chinese.</Citation>
        </Reference>
        <Reference>
          <Citation>Su MX, Da YW, Yang BF, et al. A case report of young female with lowerlimnbs stiffness for 20 years, fatigue and weakness for 1 month-Myotonia congenita and Hoffmann syndrome. Chin J Nerv Ment Dis. 2020;46(12):759–762R. Chinese.</Citation>
        </Reference>
        <Reference>
          <Citation>Song J, Zhang JW, Li G, et al. Clinical and genetic features of three Chinese patients with myotonia congenita. J Apoplexy Nervous Dis. 2021;38(3):249–252. Chinese.</Citation>
        </Reference>
        <Reference>
          <Citation>Lehmann-Horn F, Rudel R, Ricker K. Non-dystrophic myotonias and periodic paralyses. A European neuromuscular center workshop held 4-6 October 1992, Ulm, Germany. Neuromuscul Disord. 1993;3(2):161–168.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7689382</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Burgunder JM, Huifang S, Beguin P, et al. Novel chloride channel mutations leading to mild myotonia among Chinese. Neuromuscul Disord. 2008;18(8):633–640.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18579381</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jou SB, Chang LI, Pan H, et al. Novel CLCN1 mutations in Taiwanese patients with myotonia congenita. J Neurol. 2004;251(6):666–670.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15311340</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen ZT, He J, and Chen WJ, et al. Analysis of CLCN1 gene mutations in 2 patients with myotonia congenita. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2012;29(6):690–692. Chinese.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23225051</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fialho D, Kullmann DM, Hanna MG, et al. Non-genomic effects of sex hormones on CLC-1 may contribute to gender differences in myotonia congenita. Neuromuscul Disord. 2008;18(11):869–872.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18815035</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vereb N, Montagnese F, Glaser D, et al. Non-dystrophic myotonias: clinical and mutation spectrum of 70 German patients. J Neurol. 2021;268(5):1708–1720.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8068660</ArticleId>
            <ArticleId IdType="pubmed">33263785</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Heatwole CR, Statland JM, Logigian EL. The diagnosis and treatment of myotonic disorders. Muscle Nerve. 2013;47(5):632–648.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23536309</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nojszewska M, Lusakowska A, Gawel M, et al. The needle EMG findings in myotonia congenita. J Electromyogr Kinesiol. 2019;49:102362.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31610484</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dupre N, Chrestian N, Bouchard JP, et al. Clinical, electrophysiologic, and genetic study of non-dystrophic myotonia in French-Canadians. Neuromuscul Disord. 2009;19(5):330–334.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18337100</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stunnenberg BC, Raaphorst J, Groenewoud HM, et al. Effect of mexiletine on muscle stiffness in patients with nondystrophic myotonia evaluated using aggregated N-of-1 trials. JAMA. 2018;320(22):2344–2353.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6583079</ArticleId>
            <ArticleId IdType="pubmed">30535218</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Andersen G, Hedermann G, Witting N, Andersen G, Hedermann G, Witting N, et al . The antimyotonic effect of lamotrigine in non-dystrophic myotonias: a double-blind randomized study. Brain. 2017;140(9):2295–2305.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29050397</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Modoni A, D’Amico A, Primiano G, et al. Long-term safety and usefulness of mexiletine in a large cohort of patients affected by non-dystrophic myotonias. Front Neurol. 2020;11:300.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7326038</ArticleId>
            <ArticleId IdType="pubmed">32655465</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Orsini C, Petillo R, D’Ambrosio P, et al. CLCN1 molecular characterization in 19 South-Italian patients with dominant and recessive type of myotonia congenita. Front Neurol. 2020;11:63.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7016095</ArticleId>
            <ArticleId IdType="pubmed">32117024</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fialho D, Schorge S, Pucovska U, et al. Chloride channel myotonia: exon 8 hot-spot for dominant-negative interactions. Brain. 2007;130(Pt 12):3265–3274.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17932099</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sasaki R, Nakaza M, Furuta M, et al. Mutation spectrum and health status in skeletal muscle channelopathies in Japan. Neuromuscul Disord. 2020;30(7):546–553.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">32660787</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Miao J, Wei XJ, Liu XM, et al. A case report: autosomal recessive Myotonia congenita caused by a novel splice mutation (c.1401+1G&gt;A) in CLCN1 gene of a Chinese Han patient. BMC Neurol. 2018;18(1):154.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6151044</ArticleId>
            <ArticleId IdType="pubmed">30243293</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Meyer-Kleine C, Steinmeyer K, Ricker K, et al. Spectrum of mutations in the major human skeletal muscle chloride channel gene (CLCN1) leading to myotonia. Am J Hum Genet. 1995;57(6):1325–1334.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1801423</ArticleId>
            <ArticleId IdType="pubmed">8533761</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Meng YX, Zhao Z, Shen HR, et al. Identification of novel mutations of the CLCN1 gene for myotonia congenital in China. Neurol Res. 2016;38(1):40–44.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27118449</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Esteban J, Neumeyer AM, McKenna-Yasek D, et al. Identification of two mutations and a polymorphism in the chloride channel CLCN-1 in patients with Becker’s generalized myotonia. Neurogenetics. 1998;1(3):185–188.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10737121</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang J, George AL Jr., Griggs RC, et al. Mutations in the human skeletal muscle chloride channel gene (CLCN1) associated with dominant and recessive myotonia congenita. Neurology. 1996;47(4):993–998.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8857733</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Duno M, Colding-Jorgensen E, Grunnet M, et al. Difference in allelic expression of the CLCN1 gene and the possible influence on the myotonia congenita phenotype. Eur J Hum Genet. 2004;12(9):738–743.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15162127</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Milla CP, De Castro CP, Gomez-Gonzalez C, et al. Myotonia congenita: mutation spectrum of CLCN1 in Spanish patients. J Genet. 2019;98:98.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31544778</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Brugnoni R, Kapetis D, Imbrici P, et al. A large cohort of myotonia congenita probands: novel mutations and a high-frequency mutation region in exons 4 and 5 of the CLCN1 gene. J Hum Genet. 2013;58(9):581–587.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23739125</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Skalova D, Zidkova J, Vohanka S, et al. CLCN1 mutations in Czech patients with myotonia congenita, in silico analysis of novel and known mutations in the human dimeric skeletal muscle chloride channel. PLoS One. 2013;8(12):e82549.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3859631</ArticleId>
            <ArticleId IdType="pubmed">24349310</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Koty PP, Pegoraro E, Hobson G, et al. Myotonia and the muscle chloride channel: dominant mutations show variable penetrance and founder effect. Neurology. 1996;47(4):963–968.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8857727</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
